G

Glaukos Corp
D

GKOS

148.550
USD
-2.42
(-1.60%)
مغلق
حجم التداول
16,966
الربح لكل سهم
-2
العائد الربحي
-
P/E
-51
حجم السوق
8,190,665,078
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALGN
    -3.540
    (-1.68%)
    207.590 USD
    A
    ATEC
    -0.23500
    (-2.52%)
    9.10500 USD
    EW
    EW
    0.000
    (0.00%)
    74.820 USD
    I
    ICUI
    -2.260
    (-1.44%)
    154.470 USD
    ISRG
    ISRG
    2.11
    (0.40%)
    527.02 USD
    JNJ
    JNJ
    0.780
    (0.54%)
    145.230 USD
    MDT
    MDT
    0.380
    (0.47%)
    81.400 USD
    N
    NUVA
    -0.720
    (-1.77%)
    39.980 USD
    SYK
    SYK
    2.14
    (0.59%)
    366.68 USD
    المزيد
الأخبار
المقالات

العنوان: Glaukos Corp

القطاع: Healthcare
الصناعة: Medical Devices
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.